Interdisciplinary Graduate School of Agriculture and Engineering, University of Miyazaki, Miyazaki, Japan.
School of Marine Biosciences, Kitasato University, Sagamihara, Japan.
Front Immunol. 2020 Mar 17;11:425. doi: 10.3389/fimmu.2020.00425. eCollection 2020.
In mammals, interleukin (IL)-17A and F are hallmark inflammatory cytokines that play key roles in protection against infection and intestinal mucosal immunity. In the gastrointestinal tract (GI), the induction of antimicrobial peptide (AMP) production via Paneth cells is a fundamental role of IL-17A and F in maintaining homeostasis of the GI microbiome and health. Although mammalian IL-17A and F homologs (referred to as IL-17A/F1-3) have been identified in several fish species, their function in the intestine is poorly understood. Additionally, the fish intestine lacks Paneth cells, and its GI structure is very different from that of mammals. Therefore, the GI microbiome modulatory mechanism via IL-17A/F genes has not been fully elucidated. In this study, Japanese medaka () were used as a teleost model, and IL-17A/F1-knockout (IL-17A/F1-KO) medaka were established using the CRISPR/Cas9 genome editing technique. Furthermore, two IL-17A/F1-deficient medaka strains were generated, including one strain containing a 7-bp deletion (-7) and another with an 11-bp addition (+11). After establishing F2 homozygous KO medaka, transcriptome analysis (RNA-seq) was conducted to elucidate IL-17A/F1-dependent gene induction in the intestine. Results of RNA-seq and real-time PCR (qPCR) demonstrated down-regulation of immune-related genes, including interleukin-1β (β), complement 1q subunit C (), transferrin a (), and G-type lysozyme (), in IL-17A/F1-KO medaka. Interestingly, protein and lipid digestive enzyme genes, including phospholipase A2, group IB (), and elastase-1-like (), were also downregulated in the intestines of IL-17A/F1-KO medaka. Furthermore, to reveal the influence of these downregulated genes on the gut microbiome in IL-17A/F1-KO, 16S rRNA-based metagenomic sequencing analysis was conducted to analyze the microbiome constitution. Under a non-exposed state, the intestinal microbiome of IL-17A/F1-KO medaka differed at the phylum level from wild-type, with significantly higher levels of Verrucomicrobia and Planctomycetes. Additionally, at the operational taxonomic unit (OTU) level of the human and fish pathogens, the Enterobacteriaceae was the dominant species in IL-17A/F1-KO medaka. These findings suggest that IL-17A/F1 is involved in the maintenance of a healthy gut microbiome.
在哺乳动物中,白细胞介素 (IL)-17A 和 F 是标志性的炎症细胞因子,它们在抗感染和肠道黏膜免疫中发挥关键作用。在胃肠道 (GI) 中,通过 Paneth 细胞诱导抗菌肽 (AMP) 的产生是 IL-17A 和 F 维持 GI 微生物组和健康的基本功能。尽管已在几种鱼类物种中鉴定出哺乳动物的 IL-17A 和 F 同源物(称为 IL-17A/F1-3),但其在肠道中的功能仍知之甚少。此外,鱼类的肠道缺乏 Paneth 细胞,其 GI 结构与哺乳动物有很大不同。因此,IL-17A/F 基因的 GI 微生物组调节机制尚未完全阐明。在这项研究中,日本青鳉 () 被用作硬骨鱼模型,并使用 CRISPR/Cas9 基因组编辑技术建立了 IL-17A/F1 敲除 (IL-17A/F1-KO) 青鳉。此外,还生成了两种 IL-17A/F1 缺陷型青鳉品系,包括含有 7 个碱基对缺失 (-7) 的品系和含有 11 个碱基对添加 (+11) 的品系。在建立 F2 纯合 KO 青鳉后,进行转录组分析 (RNA-seq) 以阐明肠道中 IL-17A/F1 依赖性基因的诱导。RNA-seq 和实时 PCR (qPCR) 的结果表明,IL-17A/F1-KO 青鳉中包括白细胞介素 1β (β)、补体 1q 亚基 C ()、转铁蛋白 a () 和 G 型溶菌酶 () 在内的免疫相关基因下调。有趣的是,IL-17A/F1-KO 青鳉肠道中的蛋白和脂质消化酶基因,包括磷脂酶 A2、IB 组 () 和弹性蛋白酶 1 样 (),也下调。此外,为了揭示这些下调的基因对 IL-17A/F1-KO 肠道微生物组的影响,进行了基于 16S rRNA 的宏基因组测序分析以分析微生物组组成。在非暴露状态下,IL-17A/F1-KO 青鳉的肠道微生物组在门水平上与野生型不同,厚壁菌门和浮霉菌门的水平显著升高。此外,在人类和鱼类病原体的分类操作单元 (OTU) 水平上,肠杆菌科是 IL-17A/F1-KO 青鳉中的优势物种。这些发现表明 IL-17A/F1 参与维持健康的肠道微生物组。